Cleared Traditional

K260824 - Gastrointestinal Videoscope Olympus GIF-2T1500

K260824 is an FDA 510(k) clearance for Gastrointestinal Videoscope Olympus GIF..., manufactured by Olympus Medical Systems Corporation. The device is a Class 2 Gastroenterology & Urology device with product code FDS cleared through the Traditional 510(k) pathway after a 167-day FDA review.

K260824 · Olympus Medical Systems Corporation · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2026
Decision
167d
Days
Class 2
Risk

K260824 is an FDA 510(k) clearance for the Gastrointestinal Videoscope Olympus GIF-2T1500. Classified as Gastroscope And Accessories, Flexible/rigid (product code FDS), Class II - Special Controls.

Submitted by Olympus Medical Systems Corporation (Hachioji-Shi, JP). The FDA issued a Cleared decision on August 27, 2026 after a review of 167 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1500 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Olympus Medical Systems Corporation devices

FDA 510(k) Submission Details - K260824

510(k) Number K260824 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 13, 2026
Decision Date August 27, 2026
Days to Decision 167 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d slower than avg
Panel avg: 131d · This submission: 167d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FDS Device Classification - Class 2, Special Controls

Product Code FDS Gastroscope And Accessories, Flexible/rigid
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition To Examine Or Perform Procedures In The Stomach. For Reusable, Flexible Endoscopes In This Product Code, Validated Reprocessing Instructions And Reprocessing Validation Data Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Consultant

Olympus Corporation of the Americas
Brenda Geary

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FDS Gastroscope And Accessories, Flexible/rigid

All 75
Devices cleared under the same product code (FDS) and FDA review panel - the closest regulatory comparables to K260824.
Disposable Distal Attachment D-201-13404
K260856 · Olympus Medical Systems Corporation · Aug 2026
Intuitive Endoluminal Gastrointestinal System (IG1000)
K253702 · Intuitive Surgical, Inc. · Aug 2026
EvoEndo Single-Use Endoscopy System
K260573 · EvoEndo, Inc. · Apr 2026
FUJIFILM Endoscope Model EG-S100XT and VS-1000 Display Unit
K250550 · Fujifilm Corporation · Feb 2026
Hood DH-084STR
K253568 · Fujifilm Corporation · Feb 2026
PENTAX Medical Video Upper GI Scopes (EG Family) (EG Family)
K251256 · Pentax of America, Inc. · Dec 2025